文献速递头颈外科

年轻与老年口腔鳞状细胞癌患者生存结局的Meta分析

Survival of Young Versus Old Patients With Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis.
PubMed 文献 · Laryngoscope · 2020-12-02

该系统综述与Meta分析纳入22项研究、共23,382例接受根治性治疗的口腔鳞状细胞癌(OCSCC)患者,其中≤40岁者2,238例(10%)。九项研究的Meta分析显示,年轻患者生存结局不劣于老年患者(HR=0.97,95%CI 0.66-1.41)。作者认为两组管理策略应相似,未来研究应纳入合并症并以40岁为标准年龄界值。

要点

  • ≤40岁年轻OCSCC患者与老年患者生存结局相似(HR=0.97,95%CI 0.66-1.41)。
  • 舌部为两组最常见亚部位:年轻组91%、老年组88%。
  • T1或T2期占年轻组80%、老年组77%,提示两组均以早期病变为主。

核心结论

  • 年轻成人OCSCC患者接受根治性治疗后的肿瘤学结局与老年患者相似。
  • 在缺乏临床相关差异的强证据前,两组患者的管理策略应相似。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、Embase、Scopus等主要数据库(Prospero注册号CRD42019127974)。
  • 纳入标准为成人组织学诊断OCSCC并接受治疗、年龄界值40岁的对照研究并报告生存结局。
  • 排除含口咽鳞状细胞癌患者或以姑息治疗为目的的患者。
  • 共纳入22项研究、23,382例接受根治性治疗的OCSCC患者,其中≤40岁者2,238例(10%)。

主要发现

  • 舌部为两组最常见亚部位:年轻组1,961例(91%),老年组18,047例(88%)。
  • T1或T2期占年轻组859例(80%)、老年组8,126例(77%)。
  • 九项研究的Meta分析显示年轻患者生存不劣于老年患者(HR=0.97,95%CI 0.66-1.41)。

关键数值与推荐

  • 年龄界值定义为40岁。
  • 九项研究Meta分析的总体生存风险比为0.97(95%CI 0.66-1.41)。

临床怎么用

  • 年轻OCSCC患者可参照老年患者采用相似的根治性治疗策略。
  • 未来研究应纳入合并症因素,并以40岁作为标准年龄界值以统一数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/HYPOTHESIS: To assess whether young patients with oral cavity squamous cell carcinoma (OCSCC) demonstrate worse oncologic outcomes than older patients after definitive therapy. STUDY DESIGN: Systematic review and meta-analysis. METHODS: A medical librarian composed a search strategy to identify relevant studies in Medline, Embase, Scopus, and other major databases (Prospero registration number CRD42019127974). Inclusion criteria were adults with histologically diagnosed OCSCC that underwent treatment, comparator groups with an age cutoff of 40 years old, and reported survival outcomes. Articles were excluded if they contained patients with oropharyngeal squamous cell carcinoma or patients treated for palliative intent. Overall survival hazard ratios were analyzed with a meta-analysis. RESULTS: There were 23,382 patients with OCSCC that were treated with definitive therapy from 22 included studies. The pooled cohort contained 2,238 (10%) patients ≤40 years of age. Oral tongue was the most common subsite in both the younger (n = 1,961, 91%) and older (n = 18,047, 88%) cohorts. The majority of OCSCCs were either T1 or T2, representing 859 (80%) malignancies in younger patients and 8,126 (77%) malignancies in older patients. A meta-analysis of nine studies demonstrated that younger patients did not experience worse survival outcomes than older patients (hazard ratio = 0.97, 95% confidence interval = 0.66-1.41). CONCLUSIONS: Young adults with OCSCC experienced similar oncologic outcomes as older patients with OCSCC after definitive treatment. Until compelling evidence demonstrates clinically relevant differences between these two cohorts, their approach to management should be similar. Future studies should consider comorbidities and using age 40 as a standard age cutoff to provide more uniform data moving forward. Laryngoscope, 131:1310-1319, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lee DS, Ramirez RJ, Lee JJ, et al. Survival of Young Versus Old Patients With Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis. Laryngoscope. 2020. PMID: 33264444. doi:10.1002/lary.29260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。